Your browser doesn't support javascript.
loading
A novel insulin combination of insulin degludec and insulin aspart achieves a more stable overnight glucose profile than insulin glargine: results from continuous glucose monitoring in a proof-of-concept trial.
Liebl, Andreas; Davidson, Jaime; Mersebach, Henriette; Dykiel, Patrik; Tack, Cees J; Heise, Tim.
Affiliation
  • Liebl A; Department for Internal Medicine, Center for Diabetes and Metabolism, Fachklinik Bad Heilbrunn, Woernerweg 30, D-83670 Bad Heilbrunn, Germany. andreas.liebl@fachklinik-bad-heilbrunn.de.
J Diabetes Sci Technol ; 7(5): 1328-36, 2013 Sep 01.
Article in En | MEDLINE | ID: mdl-24124961
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Insulin Aspart / Hypoglycemic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Diabetes Sci Technol Journal subject: ENDOCRINOLOGIA Year: 2013 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Insulin Aspart / Hypoglycemic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Diabetes Sci Technol Journal subject: ENDOCRINOLOGIA Year: 2013 Document type: Article Affiliation country: Germany Country of publication: United States